NCT03492619 is a NA clinical trial of Intensive Intervention in Obesity, sponsored by University of South Carolina.

Who is sponsoring NCT03492619?

NCT03492619 is sponsored by University of South Carolina.

What drugs are being tested in NCT03492619?

Interventions in NCT03492619: Intensive Intervention, Non-Intensive Intervention.

What condition does NCT03492619 study?

NCT03492619 studies Obesity, Food Habits, Mental Depression.

Is NCT03492619 still recruiting?

NCT03492619 is currently completed. Last updated 10 April 2018.

Last reviewed 2018-04-10 · How we verify

NCT03492619

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intervention for Women in Costa Rica

Completed NA Last updated 10 April 2018

What this trial tests

NA trial testing Intensive Intervention in Obesity in 171 participants. Completed in 15 December 2017.

Timeline

1 February 2017

Primary endpoint
30 November 2017

15 December 2017

Quick facts

Lead sponsor	University of South Carolina
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	171
Start date	1 February 2017
Primary completion	30 November 2017
Estimated completion	15 December 2017
Sites	1 location across Costa Rica

Drugs / interventions tested

Intensive Intervention
Non-Intensive Intervention

Conditions studied

Obesity — all drugs for Obesity →
Food Habits — all drugs for Food Habits →
Mental Depression — all drugs for Mental Depression →

Sponsor

University of South Carolina

Who can join

Adults 18 to 60, female only, with Obesity or Food Habits. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study develops, implements, and evaluates an intervention focused on alleviating discouragement, food insecurity, and excess weight in women,targeted at the individual, family, and community levels in the Canton Central of the province of Alajuela, Costa Rica.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Intensive Intervention

Trials testing the same drug.

NCT03512457 — Skin Self-Examination Education During Mammography · NA · completed

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other University of South Carolina trials

Trials by the same sponsor.

NCT06469749 — Theory-based Social Media Intervention for Non-medical Use of Prescription Opioids in Young Adults · NA · not yet recruiting
NCT07340580 — Implementation Facilitation of Exercise is Medicine Greenville · NA · not yet recruiting
NCT07518407 — Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy · NA · not yet recruiting
NCT07340099 — Church Implementation of a Social Support Intervention to Increase Physical Activity in Older African American Adults · NA · not yet recruiting
NCT06024317 — Leveraging Community Health Workers and a Digital Health System to Improve the Timeliness of Child Well Visits · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03492619 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of South Carolina
Last refreshed: 10 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03492619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing